We are live on !
Find out more
MB, Levis & Associates Portfolio holdings
AUM
$273M
Turnover
5.79%
1-Year Est. Return
8.08%
This Fund
S&P 500
This Quarter Est. Return
-1.55%
1 Year Est. Return
+8.08%
3 Year Est. Return
+43.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$1.42M
(+0.52%)
Cap. Flow
+$7.56M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
61.4%
Holding
259
New
5
Increased
81
Reduced
40
Closed
10
Avg Time Held
2.9
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBonds Dec 2036 Term Corporate ETF
IBCB
|
+$5.66M |
| 2 |
Vanguard Core Tax-Exempt Bond ETF
VCRM
|
+$2.9M |
| 3 |
Capital Group Municipal Income ETF
CGMU
|
+$2.24M |
| 4 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$1.01M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$781K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
|
+$6.08M |
| 2 |
iShares iBonds Dec 2035 Term Corporate ETF
IBCA
|
+$260K |
| 3 |
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
|
+$200K |
| 4 |
NVIDIA
NVDA
|
+$172K |
| 5 |
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
|
+$166K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 77.58% |
| 2 | Technology | 6.1% |
| 3 | Industrials | 4.66% |
| 4 | Healthcare | 3.41% |
| 5 | Financials | 2.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Crown Castle
CCI
$37.4B
| $15.3K | 0.01% |
230
| – | – |
2022 Q4
15 quarters
|
|
152
Nutrien
NTR
$34.3B
| $13.1K | ﹤0.01% |
187
| – | – |
2022 Q4
15 quarters
|
|
153
Sprott
SII
$2.99B
| $13.1K | ﹤0.01% |
110
| – | – |
2022 Q4
15 quarters
|
|
154
Citigroup
C
$202B
| $12.7K | ﹤0.01% |
98
| – | – |
2022 Q4
15 quarters
|
|
155
Archer Daniels Midland
ADM
$33.2B
| $12.6K | ﹤0.01% |
158
| – | – |
2022 Q4
15 quarters
|
|
156
Walt Disney
DIS
$206B
| $12.3K | ﹤0.01% |
117
-25
| -18% | -$2.56K |
2022 Q4
15 quarters
|
|
157
iShares MSCI China ETF
MCHI
$5.78B
| $11.9K | ﹤0.01% |
228
| – | – |
2022 Q4
15 quarters
|
|
158
Apollo Global Management
APO
$72.2B
| $11.6K | ﹤0.01% |
100
| – | – |
2022 Q4
15 quarters
|
|
159
iShares Russell 3000 ETF
IWV
$20.2B
| $11.5K | ﹤0.01% |
27
| – | – |
2022 Q4
15 quarters
|
|
160
Columbia Seligman Premium Technology Growth Fund
STK
$884M
| $11.3K | ﹤0.01% |
210
| – | – |
2026 Q2
1 quarter
|
|
161
Columbia Financial
CLBK
$3.06B
| $11.1K | ﹤0.01% |
+1,000
| New | +$11K |
2026 Q3
0 quarters
|
|
162
Fresenius Medical Care
FMS
$11.9B
| $10.7K | ﹤0.01% |
478
| – | – |
2022 Q4
15 quarters
|
|
163
Shell
SHEL
$280B
| $10.7K | ﹤0.01% |
112
+1
| +0.9% | +$90 |
2022 Q4
15 quarters
|
|
164
AdvisorShares Dorsey Wright ADR ETF
AADR
$33.8M
| $10.6K | ﹤0.01% |
130
| – | – |
2026 Q2
1 quarter
|
|
165
CrowdStrike
CRWD
$234B
| $10.6K | ﹤0.01% |
40
| – | – |
2022 Q4
15 quarters
|
|
166
SpaceX
SPCX
$1.93T
| $10.6K | ﹤0.01% |
70
| – | – |
2026 Q2
1 quarter
|
|
167
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.94B
| $10.3K | ﹤0.01% |
1,092
| – | – |
2026 Q2
1 quarter
|
|
168
Essex Property Trust
ESS
$17.7B
| $10K | ﹤0.01% |
37
| – | – |
2022 Q4
15 quarters
|
|
169
Lam Research
LRCX
$277B
| $9.9K | ﹤0.01% |
30
-5
| -14% | -$1.56K |
2026 Q1
2 quarters
|
|
170
DT Midstream
DTM
$11.9B
| $9.8K | ﹤0.01% |
82
| – | – |
2022 Q4
15 quarters
|
|
171
Stryker
SYK
$124B
| $9.6K | ﹤0.01% |
35
| – | – |
2022 Q4
15 quarters
|
|
172
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$330M
| $9.3K | ﹤0.01% |
503
| – | – |
2026 Q2
1 quarter
|
|
173
Intuitive Surgical
ISRG
$160B
| $8.54K | ﹤0.01% |
21
| – | – |
2022 Q4
15 quarters
|
|
174
Vanguard Core Plus Bond ETF
VPLS
$2.51B
| $8.36K | ﹤0.01% |
113
+1
| +0.9% | +$76 |
2024 Q1
10 quarters
|
|
175
First Trust RBA American Industrial Renaissance ETF
AIRR
$8.38B
| $8.26K | ﹤0.01% |
80
-20
| -20% | -$2.31K |
2023 Q3
12 quarters
|
|
Similar funds
AGC
LP
MEPT
MB, Levis & Associates's Q3 2026 Portfolio in Review
As of Q3 2026, MB, Levis & Associates held 259 positions worth $273M, up 0.52% from $271M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
MB, Levis & Associates's Q3 2026 filing shows 5 new, 81 increased, 40 reduced and 10 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 220 shares worth $22.1K. The largest sale was iShares iBonds Dec 2032 Term Corporate ETF, an estimated $6.08M.
By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, down from 78% a quarter earlier, followed by Technology and Industrials.
- MB, Levis & Associates's largest Q3 2026 buy was iShares 0-3 Month Treasury Bond ETF: 220 shares worth $22.1K.
- MB, Levis & Associates added most to iShares iBonds Dec 2036 Term Corporate ETF in Q3 2026, an estimated $5.66M increase.
- MB, Levis & Associates's biggest Q3 2026 reduction was iShares iBonds Dec 2032 Term Corporate ETF, cutting an estimated $6.08M.
- MB, Levis & Associates fully exited iShares Russell 1000 ETF in Q3 2026, selling an estimated $46.7K.
- MB, Levis & Associates's ten largest holdings make up 61% of its $273M portfolio in Q3 2026.
- MB, Levis & Associates opened 5 new positions and closed 10 in Q3 2026.
- MB, Levis & Associates's portfolio value rose 0.52% quarter-over-quarter to $273M.
Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.